Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis
Condition: Deep Fibromatosis/Desmoid TumorInterventions: Drug: Sorafenib Tosylate; Other: Placebo; Other: Laboratory Biomarker Analysis; Other: Quality-of-Life AssessmentSponsor: National Cancer Institute (NCI)Recruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 17, 2014 Category: Research Source Type: clinical trials
Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis
Condition: Deep Fibromatosis/Desmoid TumorInterventions: Other: Laboratory Biomarker Analysis; Other: Placebo; Other: Quality-of-Life Assessment; Drug: Sorafenib TosylateSponsor: National Cancer Institute (NCI)Recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 17, 2014 Category: Research Source Type: clinical trials
Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis
Condition: Deep Fibromatosis/Desmoid TumorInterventions: Drug: Sorafenib Tosylate; Other: Placebo; Other: Laboratory Biomarker Analysis; Other: Quality-of-Life AssessmentSponsor: National Cancer Institute (NCI)Recruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 17, 2014 Category: Research Source Type: clinical trials
Observational Prospective Study on Patients With Symptomatic Uterine Fibroids Treated With VizAblate® Intrauterine-ultrasound Guided RF Ablation
Conditions: Menorrhagia; Leiomyoma; Uterine Fibroids; Uterine Fibroma; Uterine NeoplasmsIntervention: Device: VizAblate SystemSponsor: GynesonicsTerminated - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 25, 2013 Category: Research Source Type: clinical trials
Observational Prospective Study on Patients With Symptomatic Uterine Fibroids Treated With VizAblate® Intrauterine-ultrasound Guided RF Ablation
Conditions: Menorrhagia; Leiomyoma; Uterine Fibroids; Uterine Fibroma; Uterine NeoplasmsIntervention: Device: VizAblate SystemSponsor: GynesonicsTerminated - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 25, 2013 Category: Research Source Type: clinical trials
Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive Fibromatosis
Conditions: Desmoid Tumors; Aggressive FibromatosisIntervention: Drug: PF-03084014Sponsors: National Cancer Institute (NCI); National Institutes of Health Clinical Center (CC)Active, not recruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 8, 2013 Category: Research Source Type: clinical trials
Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive Fibromatosis
Conditions: Desmoid Tumors; Aggressive FibromatosisIntervention: Drug: PF-03084014Sponsor: National Cancer Institute (NCI)Active, not recruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 31, 2013 Category: Research Source Type: clinical trials
